Peck-Radosavljevic, M., Abdelgafur, A., Granito, A., Gasbarrini, A., Ma, Y. T., Mena, E., Lledó-Navarro, J. L., Presa, J., Weinmann, A., Levy, M. T., Pellicelli, A., Waldschmidt, D. T.
, Sørensen, H. T., Goyal, L., Ren, M., Saal, H., Okpara, C. E. & Meyer, T. (2026).
An International Phase 4 Study of Lenvatinib and Sorafenib in Real-World Patients with Unresectable Hepatocellular Carcinoma: Final Analysis.
Liver Cancer, 1-11.
https://doi.org/10.1159/000552115
Olesen, T. B., Therkildsen, S. B., Viborg, P. H., Brander, N., Friis-Hansen, L., Høyrup, M., Jensen, H., Kjær-Frifeldt, S., Pedersen, L., Sjöström, M., Søndergaard, B., Rasmussen, M.
& Andersen, B. (2026).
Corrigendum to ‘Performance of FIT-based colorectal cancer screening in Denmark from 2014 to 2022’(European Journal of Cancer, (2026), 241, C, (116788), (S0959804926005691), 10.1016/j.ejca.2026.116788).
European Journal of Cancer,
243, Article 116873.
https://doi.org/10.1016/j.ejca.2026.116873